Inactive Instrument
Earth Science Tech, Inc. Stock Other OTC
Stocks
ETST
US2703111037
Pharmaceuticals
OTC Markets Traded| Market Cap | 30.14M 26.12M 24.45M 22.31M 41.98M 2.87B 42.69M 287M 112M 1.44B 113M 111M 4.8B | P/E 2027 * |
10.5x | P/E 2028 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 30.14M 26.12M 24.45M 22.31M 41.98M 2.87B 42.69M 287M 112M 1.44B 113M 111M 4.8B | EV / Sales 2027 * |
0.72x | EV / Sales 2028 * | 0.69x |
| Free-Float |
33.37% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Earth Science Tech, Inc.
| 1 day | -5.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Giorgio Saumat
CEO | Chief Executive Officer | 47 | 13/02/2023 |
Ernesto Flores
DFI | Director of Finance/CFO | 41 | 04/03/2024 |
Mario Tabraue
PSD | President | 47 | 01/11/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Tabraue
BRD | Director/Board Member | 47 | 01/11/2021 |
Jeff Cazeau
BRD | Director/Board Member | 58 | 13/02/2023 |
Giorgio Saumat
CHM | Chairman | 47 | 01/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.08% | -10.57% | - | - | 30.14M | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,083B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 626B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 442B | |
| -1.13% | +3.13% | +49.78% | +39.13% | 363B | |
| -0.74% | +1.01% | +31.08% | +38.64% | 295B | |
| -1.22% | +0.89% | +7.32% | +7.38% | 248B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 224B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 210B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 168B | |
| Average | -0.78% | +1,662.85% | +34.23% | +45.11% | 406.57B | |
| Weighted average by Cap. | -0.62% | +1,332.62% | +49.63% | +66.05% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.04M 36.43M 34.11M 31.12M 58.56M 4.01B 59.55M 400M 157M 2.01B 158M 154M 6.7B | 43.98M 38.12M 35.68M 32.56M 61.27M 4.2B 62.3M 418M 164M 2.1B 165M 162M 7.01B |
| Net income | - | 3.85 3.34 3.12 2.85 5.36 367.21 5.45 36.62 14.35 183.8 14.46 14.14 613.18 |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
